期刊文献+

7例真菌性败血症的临床分析 被引量:15

Clinical Analysis of 7 Patients with Fungal Septicaemia
原文传递
导出
摘要 目的探讨医院内真菌性败血症的临床特点与治疗方法。方法对1999-2009年7例真菌败血症患者进行回顾性临床分析。结果7例中,易感危险因素以严重基础疾病(100.0%)、使用广谱抗菌药物(86.0%)、应用糖皮质激素(57.0%)最为突出;主要病原菌为假丝酵母菌属包括白色假丝酵母菌和非白色假丝酵母菌(热带假丝酵母菌、克柔假丝酵母菌);病死率为86.0%。结论败血症多发生在机体免疫功能降低的患者中,主要病原菌为白色假丝酵母菌和非白色假丝酵母菌,应早期开展经验性治疗,目前临床应用氟康唑抗真菌治疗剂量偏小。 OBJECTIVE To study on the clinical features and treatment method for fungemia. METHODS The clinical features, therapy and outcome of 7 patients with fungemia which happened from 1999 to 2009 were retrospectively reviewed. RESULTS The main underlying conditions were : malignant disease in 7 patients (100%). In this group the risk factors for fungemia included: prior antimicrobial therapy (86%), steroids chemotherapy (57%). Fungal species isolated from 7 patients were; c. albicans (5), c. tropicalis (2). The overall mortality of fungemia was 86%. CONCLUSIONS In this study,the most frequent infectious agents were Candida albicans and non albicans Candida specis. Experience therapy should be begun earlier. Higher dose of fluconazole may be recommended in clinical usage.
作者 石荔 羊红燕
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2009年第21期2873-2874,共2页 Chinese Journal of Nosocomiology
关键词 真菌败血症 氟康唑 预后 Fungemia Fluconazole Prognosis
  • 相关文献

参考文献7

  • 1Costa SF, Marinho I, Araujo EA, et al. Nosocomial fungemia: a 22year prospective study[J]. J Hosp Infect, 2000,45 : 69-72. 被引量:1
  • 2医院感染诊断标准(试行)[J].中华医学杂志,2001,81(5):314-320. 被引量:5840
  • 3李湘燕,赵彩芸.真菌败血症17例回顾性临床分析[J].中华医院感染学杂志,2006,16(11):1241-1243. 被引量:15
  • 4廖万清,吴绍熙主编..病原真菌生物学研究与应用[M].北京:化学工业出版社,2006:239.
  • 5NueeiM, Brasah I, AkitiT, et al. A double-blind. Randomized. placebo-controlled tnal of itraeonazole capsules as antrfungal prophylaxis for neutropenie patients[J]. Clin Infect Dis,2000,30(2):300-305. 被引量:1
  • 6贾杰.现代真菌学[M].郑州:郑州大学出版社,2001.. 被引量:3
  • 7Eloy O, Blanc V, Pina P, et al. Epidemiology of eandidemia: results of a one month French hospitals-based surveillance study in 2004[J]. Pathol Biol(Paris), 2006,54(8-9) : 523-530. 被引量:1

二级参考文献6

  • 1Asmundsdottir LR,Erlendsdottir H,Gottfredsson M.Improving survival of patients with candidaemia:analysis of prognostic factors from a long-term,nationwide study in Iceland[J].Scand J Infect Dis,2005,37(2):111-120. 被引量:1
  • 2Almirante B,Rodriguez D,Park BJ,et al.Epidemiology and predictors of mortality in cases of Candida bloodstream infection:results from population-based surveillance,Barcelona,Spain,from 2002 to 2003[J].J Clin Microbiol,2005,43(4):1829-1835. 被引量:1
  • 3Marco F,Danes C,Almela M,et al.Trends in frequency and in vitro susceptibilities to antifungal agents,including voriconazole and anidulafungin,of Candida bloodstream isolates.Results from a six-year study (1996-2001)[J].Diagn Microbiol Infect Dis,2003,46(4):259-264. 被引量:1
  • 4Peman J,Canton E,Gobernado M,et al.Epidemiology and antifungal susceptibility of Candida species isolated from blood:results of a 2-year multicentre study in Spain[J].Eur J Clin Microbiol Infect Dis,2005,24(1):23-30. 被引量:1
  • 5Torres HA,Kontoyiannis DP,Rolston KV.High-dose fluconazole therapy for cancer patients with solid tumors and support care[J].Cancer,2004,12(7):511-516. 被引量:1
  • 6Piarroux R,Grenouillet F,Balvay P,et al.Assessment of preemptive treatment to prevent severe candidiasis in critically ill surgical patients[J].Crit Care Med,2004,32(12):2443-2449. 被引量:1

共引文献5853

同被引文献70

引证文献15

二级引证文献77

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部